Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)

Psychiatrist.com

Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study

Psychiatry October 18th 2023

Psych Congress Network

Brain Fitness Program Improves Symptoms in Patients with ADHD, PCS, Memory Loss

Neurology October 3rd 2023

MDLinx

Are You Prescribing ADHD Medication Correctly? Poison Centers See a 300% Rise in Reports Related to Possible Prescription Errors

Psychiatry September 27th 2023

Psych Congress Network

Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective

Pediatrics September 27th 2023

Psych Congress Network

“Unmasking” ADHD in Aging Patients with Comorbidities

Psychiatry September 12th 2023

Psych Congress Network

Understanding the Stimulant Shortage

Psychiatry September 12th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form